Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis

BACKGROUND: Endostatin (ES) inhibits endothelial cell proliferation, migration, invasion, and tube formation. It also shows antiangiogenesis and antitumor activities in several animal models. Endostatin specifically targets tumor vasculature to block tumor growth. Lidamycin (LDM), which consists of...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jiang, Wen-guo, Lu, Xin-an, Shang, Bo-yang, Fu, Yan, Zhang, Sheng-hua, Zhou, Daifu, Li, Liang, Li, Yi, Luo, Yongzhang, Zhen, Yong-su
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2013
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4016579/
https://ncbi.nlm.nih.gov/pubmed/24128285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-479
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы